EPHA6 and neoplasm: In their report, shRNA targeting a common region of both full-length and truncated splice variants of EPHA6 seemed to decrease tumor angiogenesis and metastasis to a larger degree, compared with an shRNA that targeted only full length EPHA6 [31].